tendinitis 发表于 2025-3-23 13:29:17

http://reply.papertrans.cn/1/74/7396/7396-11.png

COMMA 发表于 2025-3-23 17:07:41

http://reply.papertrans.cn/1/74/7396/7396-12.png

delusion 发表于 2025-3-23 19:24:11

Submitted on: 13 February 1999.
Revised on: 30 May 1999.
Accepted on: 19 July 1999.

___________________Diabetes Technology & Therapeutics

oxidant 发表于 2025-3-24 01:20:39

Submitted on: 15 May 2024.
Revised on: 04 August 2024.
Accepted on: 21 September 2024.

___________________Diabetes Technology & Therapeutics

多山 发表于 2025-3-24 02:32:50

Submitted on: 23 December 2013.
Revised on: 18 April 2014.
Accepted on: 05 May 2014.

___________________Diabetes Technology & Therapeutics

奇怪 发表于 2025-3-24 07:38:01

http://reply.papertrans.cn/1/74/7396/7396-16.png

DRAFT 发表于 2025-3-24 11:51:06

http://reply.papertrans.cn/1/74/7396/7396-17.png

appall 发表于 2025-3-24 15:18:31

http://reply.papertrans.cn/1/74/7396/7396-18.png

流逝 发表于 2025-3-24 21:17:11

http://reply.papertrans.cn/1/74/7396/7396-19.png

inventory 发表于 2025-3-24 23:59:13

Submitted on: 14 July 2022.
Revised on: 27 August 2022.
Accepted on: 26 September 2022.

___________________Diabetes Technology & Therapeutics
页: 1 [2] 3 4
查看完整版本: SCIE期刊Diabetes Technology & Therapeutics 2024/2025影响因子:5.768 (DIABETES TECHNOL THE) (1520-9156). (ENDOCRINOLOGY & METAB